Parmax Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE240T01014
  • NSEID:
  • BSEID: 540359
INR
135.10
0.00 (0.00%)
BSENSE

Nov 20

BSE+NSE Vol: 5.33 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002724,
    "name": "Parmax Pharma",
    "stock_name": "Parmax Pharma",
    "full_name": "Parmax Pharma Ltd",
    "name_url": "stocks-analysis/parmax-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "135.10",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "135.10",
    "mcapval": "93.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540359,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE240T01014",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "5.33 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/parmax-pharma-1002724-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Parmax Pharma Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/parmax-pharma-ltd-is-rated-sell-4269270",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ParmaxPharmaLtd_mojoScore_4269270.png",
        "date": "2026-11-20 10:10:35",
        "description": "Parmax Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 20 November 2026, providing investors with an up-to-date analysis of the company’s standing."
      },
      {
        "title": "Parmax Pharma Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/parmax-pharma-ltd-is-rated-sell-4246428",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ParmaxPharmaLtd_mojoScore_4246428.png",
        "date": "2026-11-01 10:10:05",
        "description": "Parmax Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Parmax Pharma Stagnates at Rs.139.10 Despite Market Volatility: Key Weekly Insights",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/parmax-pharma-stagnates-at-rs13910-despite-market-volatility-key-weekly-insights-4221119",
        "imagepath": "",
        "date": "2026-10-10 13:02:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>05 Oct:</strong> Parmax Pharma Ltd hits new 52-week and all-time high at Rs.139.10</p>\n                    <p><strong>06-09 Oct:</strong> Stock price remains unchanged at Rs.139.10 despite Sensex volatility</p>\n                    <p><strong>09 Oct:</strong> Week closes flat at Rs.139.10, outperforming Sensex which fell 0.57%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.139.10</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.139.10</div><div class=\"stat-change positive\">+0.00%</d..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 139.1",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-at-rs1391-4214769",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ParmaxPharmaLtd_priceRelatedfactors_4214769.png",
        "date": "2026-10-05 10:44:33",
        "description": "From a 52-week low of Rs 22.6 to a new peak of Rs 139.1 on 05 Oct 2026, Parmax Pharma Ltd has surged an impressive 515% over the past year, defying the broader market’s downward trend and showcasing remarkable price momentum."
      },
      {
        "title": "Parmax Pharma Ltd Hits All-Time High of Rs 137.75 as Momentum Builds Across Timeframes",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/parmax-pharma-ltd-hits-all-time-high-at-rs13775-marking-a-milestone-4214228",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ParmaxPharmaLtd_priceRelatedfactors_4214228.png",
        "date": "2026-10-05 09:36:36",
        "description": ""
      },
      {
        "title": "Parmax Pharma Gains 0.99% Amid Market Decline: 2 Key Milestones Define Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/parmax-pharma-gains-099-amid-market-decline-2-key-milestones-define-week-4212681",
        "imagepath": "",
        "date": "2026-10-03 13:02:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Sep 28:</strong> New 52-week high and all-time high at Rs.137.75</p>\n                    <p><strong>Sep 29 - Oct 01:</strong> Price consolidation at Rs.137.75 amid declining Sensex</p>\n                    <p><strong>Oct 02:</strong> No trading data available; week closes with stock outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.136.40</div>\n                    </div>\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Close</div>\n         ..."
      },
      {
        "title": "Parmax Pharma Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/parmax-pharma-ltd-is-rated-sell-4207200",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ParmaxPharmaLtd_mojoScore_4207200.png",
        "date": "2026-09-28 10:10:05",
        "description": "Parmax Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 28 September 2026, providing investors with an up-to-date analysis of the company’s standing."
      },
      {
        "title": "Parmax Pharma Gains 1.00%: Key Milestones and Market Dynamics This Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/parmax-pharma-gains-100-key-milestones-and-market-dynamics-this-week-4205866",
        "imagepath": "",
        "date": "2026-09-26 13:02:28",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>21 Sep:</strong> Parmax Pharma Ltd hits new 52-week and all-time high at Rs.136.40</p>\n                    <p><strong>22 Sep:</strong> Stock price remains steady at Rs.136.40 amid Sensex decline</p>\n                    <p><strong>23 Sep:</strong> Price unchanged at Rs.136.40 as Sensex gains 0.56%</p>\n                    <p><strong>24 Sep:</strong> Stock price flat at Rs.136.40 despite Sensex falling 1.62%</p>\n                    <p><strong>25 Sep:</strong> Week closes at Rs.136.40 with Sensex modestly up 0.18%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</di..."
      },
      {
        "title": "Parmax Pharma Ltd Hits All-Time High of Rs 136.40 as Momentum Builds Across Timeframes",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/parmax-pharma-ltd-hits-all-time-high-at-rs13640-marking-a-significant-milestone-4199350",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ParmaxPharmaLtd_priceRelatedfactors_4199350.png",
        "date": "2026-09-21 09:35:43",
        "description": ""
      }
    ],
    "total": 96,
    "sid": "1002724",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/parmax-pharma-1002724"
  },
  "announcements": [
    {
      "caption": "Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "19-Nov-2026",
      "details": "In pursuant to Reg 23(9) the paid up capital and networth of the company does not exceed in Financial year 31st march 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-Nov-2026",
      "details": "Newspaper publication for Financial Results for quarter and half year ended 30.09.2026",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For Quarter And Half Year Ended 30.09.2026",
      "datetime": "16-Nov-2026",
      "details": "Unaudited Financial results for quarter and half year ended 30.09.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

19-Nov-2026 | Source : BSE

In pursuant to Reg 23(9) the paid up capital and networth of the company does not exceed in Financial year 31st march 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

18-Nov-2026 | Source : BSE

Newspaper publication for Financial Results for quarter and half year ended 30.09.2026

Unaudited Financial Results For Quarter And Half Year Ended 30.09.2026

16-Nov-2026 | Source : BSE

Unaudited Financial results for quarter and half year ended 30.09.2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available